Wesley S. Lobo's most recent trade in Nephros Inc was a trade of 6,389 Common Stock done at an average price of $4.8 . Disclosure was reported to the exchange on Feb. 16, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nephros Inc | Wesley S. Lobo | Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.80 per share. | 16 Feb 2022 | 6,389 | 35,168 (0%) | 0% | 4.8 | 30,667 | Common Stock |
| Nephros Inc | Wesley S. Lobo | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 57,368 | 57,368 | - | - | Stock Option (right to buy) | |
| Nephros Inc | Wesley S. Lobo | Chief Marketing Officer | Purchase of securities on an exchange or from another person at price $ 7.92 per share. | 20 Aug 2021 | 1,000 | 41,557 (0%) | 0% | 7.9 | 7,920 | Common Stock |
| Nephros Inc | Wesley S. Lobo | Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 114,178 | 114,178 | - | - | Stock Optoin (right to buy) | |
| Nephros Inc | Wesley S. Lobo | Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 40,557 | 40,557 (0%) | 0% | 0 | Common Stock |